Fabrinet Total Cost of Revenue increased by 7.5% to $1.07B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 39.0%, from $769.62M to $1.07B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 16.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $448.48M | $479.73M | $497.26M | $493.70M | $512.94M | $572.67M | $583.44M | $579.27M | $573.58M | $601.07M | $624.36M | $640.60M | $660.81M | $705.20M | $732.76M | $769.62M | $798.40M | $861.69M | $995.21M | $1.07B |
| QoQ Change | — | +7.0% | +3.7% | -0.7% | +3.9% | +11.6% | +1.9% | -0.7% | -1.0% | +4.8% | +3.9% | +2.6% | +3.2% | +6.7% | +3.9% | +5.0% | +3.7% | +7.9% | +15.5% | +7.5% |
| YoY Change | — | — | — | — | +14.4% | +19.4% | +17.3% | +17.3% | +11.8% | +5.0% | +7.0% | +10.6% | +15.2% | +17.3% | +17.4% | +20.1% | +20.8% | +22.2% | +35.8% | +39.0% |